Review
doi: 10.1016/S0733-8635(03)00126-8.
Retinoid therapy for psoriasis
Affiliations
- PMID: 15450342
- DOI: 10.1016/S0733-8635(03)00126-8
Item in Clipboard
Review
Retinoid therapy for psoriasis
Dermatol Clin.
2004 Oct.
Abstract
This article focuses on the treatment of psoriasis with acitretin, the only systemic retinoid approved for psoriasis, and also briefly discusses its predecessor, etretinate, which was replaced by acitretin in 1997 and is no longer available. The use of topical tazarotene is also discussed in detail. Combination therapy of retinoids, both topical and systemic,with phototherapy and other therapeutic agents is described. In addition, new retinoid analogues that are undergoing clinical investigation are mentioned. Finally, potential toxicities and adverse effects associated with retinoids are discussed.
Similar articles
-
Review of therapy of psoriasis: the prebiologic armamentarium.Dermatol Clin. 2004 Oct;22(4):379-88, viii. doi: 10.1016/j.det.2004.03.012. Dermatol Clin. 2004. PMID: 15450334 Review.
-
New roles for systemic retinoids.J Drugs Dermatol. 2006 May;5(5):406-9. J Drugs Dermatol. 2006. PMID: 16703775 Review.
-
Clinical safety of tazarotene in the treatment of plaque psoriasis.J Am Acad Dermatol. 1997 Aug;37(2 Pt 3):S25-32. J Am Acad Dermatol. 1997. PMID: 9270553 Review.
-
Acitretin for the treatment of psoriasis: an assessment of national trends.J Drugs Dermatol. 2011 Aug;10(8):873-7. J Drugs Dermatol. 2011. PMID: 21818508
-
Tazarotene gel: efficacy and safety in plaque psoriasis.J Am Acad Dermatol. 1997 Aug;37(2 Pt 3):S33-8. J Am Acad Dermatol. 1997. PMID: 9270554 Review.
Cited by
-
Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.J Clin Aesthet Dermatol. 2014 Apr;7(4):22-34. J Clin Aesthet Dermatol. 2014. PMID: 24765227 Free PMC article. Review.
-
Killing Two Birds with One Stone: Potential Therapies Targeting Psoriasis and Atherosclerosis at the Same Time.Int J Mol Sci. 2022 Jun 14;23(12):6648. doi: 10.3390/ijms23126648. Int J Mol Sci. 2022. PMID: 35743091 Free PMC article. Review.
-
Safety of efalizumab therapy in patients with moderate to severe psoriasis: an open-label extension of a phase IIIb trial.Drug Saf. 2008;31(8):715-26. doi: 10.2165/00002018-200831080-00008. Drug Saf. 2008. PMID: 18636790 Clinical Trial.
-
Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity.Nutrients. 2021 May 18;13(5):1703. doi: 10.3390/nu13051703. Nutrients. 2021. PMID: 34069881 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
